Recruiting
Metabolic Phenotypes in Melanoma
About this study
This is a single centre, correlative, longitudinal, biomarker study that aims to describe the metabolic features of human melanoma using mass spectrometry.
- Condition
- Melanoma
- Tested
- [U-13C]Glucose Infusion
- Sponsor
- Peter MacCallum Cancer Centre, Australia
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Melanoma
- Patient has provided written informed consent
- Male or female aged 18 years or older at written informed consent
- Presence of a known melanoma lesion requiring surgical excision or biopsy
- Patient is willing and able to comply with the protocol for the duration of the study including undergoing biopsies and receiving a stable isotope infusion (where applicable)
Exclusion 4
- Patients who meet any of the following criteria will be excluded from receiving a \[U-13C\]Glucose infusion:
- Diabetes mellitus
- Pregnancy or breast feeding
- Patients unable to comply with study procedures and follow up in the opinion of the investigator
Where
1 site, 1 recruiting
Peter Mac Callum Cancer Centre
Melbourne, Victoria, Australia
Contact
-
Aparna Rao
+61385595000 aparna.rao@petermac.org
Potential match only. Final eligibility is determined by the study team.